The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based studyResearch in context
Summary: Background: Thrombosis with thrombocytopenia syndrome (TTS) associated with viral vector COVID-19 vaccines, including ChAdOx1-S (AstraZeneca AZD1222) vaccine, can result in significant morbidity and mortality. We report the clinicopathological features of TTS following ChAdOx1-S vaccinatio...
Main Authors: | Huyen A. Tran, Lucy Deng, Nicholas Wood, Philip Choi, Sally Singleton, Lisa Clarke, Sarah Khanlari, Isis Maitland-Scott, Robert Bird, Scott Brown, Bavahuna Manoharan, Chee Wee Tan, Michael Gold, Pravin Hissaria, Shannon Melody, Sanjeev D. Chunilal S, Jim Buttery, Hazel Clothier, Nigel W. Crawford, Linny Phuong, Dominic Pepperell, Paul Effler, Claire Parker, Nicola Carter, Kristine Macartney, Megan McStea, Todd Miller, Michael Nissen, Claire Larter, Elspeth Kay, Vivien M. Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | The Lancet Regional Health. Western Pacific |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666606523002122 |
Similar Items
-
AZD1222 (ChAdOx1 nCoV-19) Vaccine: Hurdles and Visions
by: Md. Altamash Ahmad, et al.
Published: (2023-03-01) -
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
by: Marchevsky, NG, et al.
Published: (2022) -
Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination
by: Hillson, K, et al.
Published: (2021) -
Antibody Response to ChAdOx1 nCoV-19 (AZD1222) Vaccine in Kidney Transplant Recipients
by: Dharmendra S. Bhadauria, et al.
Published: (2022-10-01) -
Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital
by: Piyarat Limpawittayakul, et al.
Published: (2022-11-01)